CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF study Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

Consensus2019 Sep 6. pii: S0167-5273(19)32502-1.

JOURNAL:Int J Cardiol. Article Link

A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus

Farmakis D, Agostoni P, Baholli L et al. Keywords: acute heart failure; advanced heart failure; dobutamine; inodilators; inotropes; levosimendan; milrinone; norepinephrine

FULL TEXT PDF